AU Patent

AU2010223919B2 — Methods and compositions for cell-proliferation-related disorders

Assigned to Les Laboratoires Servier SAS · Expires 2016-03-31 · 10y expired

What this patent protects

Methods of treating and evaluating subjects having neoactive mutants are described herein.

USPTO Abstract

Methods of treating and evaluating subjects having neoactive mutants are described herein.

Drugs covered by this patent

Patent Metadata

Patent number
AU2010223919B2
Jurisdiction
AU
Classification
—
Expires
2016-03-31
Drug substance claim
No
Drug product claim
No
Assignee
Les Laboratoires Servier SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.